Evidence map›Paper›PMID 27901468›Full record

ArticleeLife2016

Loss of Frataxin activates the iron/sphingolipid/PDK1/Mef2 pathway in mammals.

Kuchuan Chen, Tammy Szu-Yu Ho, Guang Lin, Kai Li Tan, Matthew N Rasband, Hugo J Bellen

Open access · goldAbstract read
In one paragraph

Article in eLife, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Iron chelators: as therapeutic agents in diseases.Annals of medicine and surgery (2012) · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Sphingolipids in neurodegenerative diseases.Frontiers in neuroscience · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Hereditary Ataxia: A Focus on Heme Metabolism and Fe-S Cluster Biogenesis.International journal of molecular sciences · 2020
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kuchuan ChenProgram in Developmental Biology, Baylor College of Medicine, Houston, United States.
Tammy Szu-Yu HoDepartment of Neuroscience, Baylor College of Medicine, Houston, United States.
Guang LinDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States.
Kai Li TanProgram in Developmental Biology, Baylor College of Medicine, Houston, United States.
Matthew N RasbandProgram in Developmental Biology, Baylor College of Medicine, Houston, United States.ORCID 0000-0001-8184-2477
Hugo J BellenProgram in Developmental Biology, Baylor College of Medicine, Houston, United States.ORCID 0000-0001-5992-5989
Baylor College of Medicine · USHoward Hughes Medical Institute · US

Funding

Steps towards a paternal gene activation therapy for Angelman syndromeU54HD083092 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI NELSON, DAVID LOREN, NEUL, JEFFREY L · 2014 to 2019
$7.8M
Mapping and rescuing EMS-induced lethal mutations on the Drosophila X ChromosomeRC4GM096355 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI BELLEN, HUGO J · 2010 to 2010
$1.7M
Howard Hughes Medical InstituteNICHD NIH HHS U54 HD083092NIGMS NIH HHS RC4 GM096355
6 · The paper itself

Abstract

Friedreich's ataxia (FRDA) is an autosomal recessive neurodegenerative disease caused by mutations in

Indexed as

Signal TransductionAnimalsFrataxinFriedreich AtaxiaGene Knockout TechniquesHumansIronIron-Binding ProteinsMEF2 Transcription FactorsMiceProtein Serine-Threonine KinasesPyruvate Dehydrogenase Acetyl-Transferring KinaseSphingolipidsFrataxinIronIron-Binding ProteinsMEF2 Transcription FactorsPDK1 protein, humanPdk1 protein, mouseProtein Serine-Threonine KinasesPyruvate Dehydrogenase Acetyl-Transferring KinaseSphingolipidsFrataxinFriedreich's ataxiahumanironMef2mouseneurosciencePDK1sphingolipid

Identifiers

PMID27901468
PMCPMC5130293
OpenAlexW2558361797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.